JUMPptm
JUMPptm performs integrative identification and analysis of post-translational modifications (PTMs) from unenriched, ultra-deep whole-proteome mass spectrometry datasets to enable pan-PTM discovery and quantitative comparison across conditions.
Key Features:
- Integration of multiple search engines: Integrates JUMP, MSFragger, and Comet to enhance sensitivity and specificity of PTM detection.
- Iterative multi-stage strategy: Employs an iterative multi-stage strategy using de novo sequencing tags, customized database searches, peptide filtering techniques, and analysis of unassigned spectra.
- Pan-PTM identification: Identifies a wide array of PTMs including phosphorylation, methylation, acetylation, and ubiquitination from unenriched datasets.
- TMT-based quantification: Incorporates TMT-based quantification to evaluate abundance changes of PTM peptides across conditions or disease stages.
Scientific Applications:
- Alzheimer's disease proteome analysis: Applied to deep brain proteome data from Alzheimer's disease samples, identifying 34,954 unique peptides carrying various PTMs.
- Disease progression and mitochondrial acetylation: Identified 482 PTM peptides dysregulated across AD progression and a notable decrease in acetylation of multiple mitochondrial proteins.
- Tau protein PTM mapping: Mapped 60 PTM sites on the Tau protein to characterize its modification landscape.
Methodology:
Integration of JUMP, MSFragger, and Comet; iterative multi-stage analysis using de novo sequencing tags, customized database searches, peptide filtering, and analysis of unassigned spectra; and TMT-based quantitative analysis.
Topics
Details
- Cost:
- Free of charge
- Tool Type:
- command-line tool, workflow
- Operating Systems:
- Mac, Linux
- Programming Languages:
- Perl, Python
- Added:
- 11/8/2022
- Last Updated:
- 11/24/2024
Operations
Publications
Poudel S, Vanderwall D, Yuan Z, Wu Z, Peng J, Li Y. JUMPptm: Integrated software for sensitive identification of post‐translational modifications and its application in Alzheimer's disease study. PROTEOMICS. 2022;23(3-4). doi:10.1002/pmic.202100369. PMID:36094355. PMCID:PMC9957936.